Comparison of SARS-CoV-2 serological tests with different antigen targets

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

(2020) Joseph T Wu et al.   LANCET

Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses

(2020) Jieliang Chen   MICROBES AND INFECTION

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

(2020) Wei Zhang et al.   Emerging Microbes & Infections

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

(2020) Kelvin Kai-Wang To et al.   LANCET INFECTIOUS DISEASES

A serological assay to detect SARS-CoV-2 seroconversion in humans

(2020) Fatima Amanat et al.   NATURE MEDICINE

The hallmarks of COVID-19 disease

(2020) Daolin Tang et al.   PLoS Pathogens

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2

(2020) Wanbo Tai et al.   ANTIVIRAL RESEARCH

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

(2020) Lakshmanane Premkumar et al.   Science Immunology

Serological assays for emerging coronaviruses: Challenges and pitfalls

(2014) Benjamin Meyer et al.   VIRUS RESEARCH